O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+11.18%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.5B
AUM Growth
+$9.5B
(+8.1%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
1.57%
Top 10 Holdings %
Top 10 Hldgs %
34.99%
Holding
144
New
11
Increased
35
Reduced
32
Closed
10
Top Buys
| 1 |
Cigna
CI
|
$205M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$197M |
| 3 |
Gilead Sciences
GILD
|
$90.1M |
| 4 |
Viatris
VTRS
|
$65.2M |
| 5 |
Biogen
BIIB
|
$52.4M |
Top Sells
| 1 |
Centene
CNC
|
$118M |
| 2 |
HCA Healthcare
HCA
|
$100M |
| 3 |
Pfizer
PFE
|
$99M |
| 4 |
Tenet Healthcare
THC
|
$94.8M |
| 5 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$74.8M |
Sector Composition
| 1 | Healthcare | 92.98% |
| 2 | Financials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYLO
126
DELISTED
Xylo Technologies
XYLO
| $131K | ﹤0.01% | 60,000 | – | – |
|
|
BCR
127
DELISTED
CR Bard Inc.
BCR
| – | – | -58,000 | Closed | -$14.4M |
|
128
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -1,169,000 | Closed | -$40.2M |
|
129
AstraZeneca
AZN
$248B
| – | – | 0 | – | – |
|
130
Clearside Biomedical
CLSD
$28.9M
| – | – | -300,000 | Closed | -$2.38M |
|
|
131
Centene
CNC
$14.3B
| – | – | -1,655,700 | Closed | -$118M |
|
132
Cooper Companies
COO
$13.4B
| – | – | -190,800 | Closed | -$38.1M |
|
133
Exact Sciences
EXAS
$8.98B
| – | – | -602,900 | Closed | -$14.2M |
|
134
Sarepta Therapeutics
SRPT
$1.78B
| – | – | -1,054,300 | Closed | -$31.2M |
|
|
135
Tenet Healthcare
THC
$16.3B
| – | – | -5,352,000 | Closed | -$94.8M |
|
|
EGRX
136
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| – | – | -671,000 | Closed | -$55.7M |
|